Cary Street Partners Investment Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $229K | Sell |
4,957
-310
| -6% | -$14.4K | 0.11% | 204 |
|
2025
Q1 | $321K | Buy |
5,267
+830
| +19% | +$50.6K | 0.19% | 139 |
|
2024
Q4 | $251K | Sell |
4,437
-41,798
| -90% | -$2.36M | 0.16% | 141 |
|
2024
Q3 | $2.39M | Sell |
46,235
-43,683
| -49% | -$2.26M | 0.09% | 244 |
|
2024
Q2 | $3.73M | Sell |
89,918
-3,313
| -4% | -$138K | 0.15% | 160 |
|
2024
Q1 | $5.06M | Sell |
93,231
-4,947
| -5% | -$268K | 0.21% | 126 |
|
2023
Q4 | $5.04M | Sell |
98,178
-9,562
| -9% | -$491K | 0.24% | 115 |
|
2023
Q3 | $6.25M | Buy |
107,740
+7,231
| +7% | +$420K | 0.34% | 78 |
|
2023
Q2 | $6.43M | Sell |
100,509
-4,666
| -4% | -$298K | 0.41% | 60 |
|
2023
Q1 | $7.29M | Buy |
105,175
+2,562
| +2% | +$178K | 0.52% | 53 |
|
2022
Q4 | $7.38M | Sell |
102,613
-708
| -0.7% | -$50.9K | 0.54% | 51 |
|
2022
Q3 | $7.35M | Buy |
103,321
+666
| +0.6% | +$47.3K | 0.6% | 49 |
|
2022
Q2 | $7.91M | Buy |
102,655
+62,989
| +159% | +$4.85M | 0.67% | 40 |
|
2022
Q1 | $2.9M | Buy |
39,666
+15,232
| +62% | +$1.11M | 0.8% | 34 |
|
2021
Q4 | $1.52M | Buy |
24,434
+1,628
| +7% | +$101K | 0.42% | 74 |
|
2021
Q3 | $1.35M | Buy |
22,806
+2,051
| +10% | +$121K | 0.44% | 70 |
|
2021
Q2 | $1.39M | Buy |
20,755
+10,305
| +99% | +$689K | 0.45% | 68 |
|
2021
Q1 | $660K | Sell |
10,450
-15,305
| -59% | -$967K | 0.27% | 94 |
|
2020
Q4 | $1.6M | Sell |
25,755
-54,382
| -68% | -$3.37M | 0.31% | 84 |
|
2020
Q3 | $4.83M | Buy |
80,137
+75,754
| +1,728% | +$4.57M | 1.02% | 19 |
|
2020
Q2 | $257K | Hold |
4,383
| – | – | 0.36% | 86 |
|
2020
Q1 | $244K | Buy |
4,383
+235
| +6% | +$13.1K | 0.57% | 51 |
|
2019
Q4 | $266K | Buy |
+4,148
| New | +$266K | 0.29% | 96 |
|